AHF Slams Gilead for Role in Florida AIDS Drug Crisis
AHF Slams Gilead for Role in Florida AIDS Drug Crisis
AIDS group to run full page ads Sunday, April 12 in five major Florida daily newspapers blasting HIV drug maker over exorbitant prices for its lifesaving HIV drugs, which put Florida’s HIV safety net under dangerous strain
One Gilead HIV medication, Biktarvy carried an annual sticker price of nearly $61,000 per patient in 2025
AHF is running full-page ads in five major Florida daily newspapers Sunday, April 12, sharply criticizing Gilead over its drug pricing, which put Florida’s HIV safety net under dangerous strain. The “Greediad” ads will run in the Miami Herald, Sun Sentinel, Orlando Sentinel, Tampa Bay Times, and the Tallahassee Democrat.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) is continuing its blistering criticism of Gilead Sciences for its extortionate pricing for its HIV medications and the role that pricing played in Florida’s recent AIDS Drug Assistance Program (ADAP) crisis.
AHF ads blasting Gilead over its extortionate drug pricing, which put Florida’s HIV safety net & over 11,000 Floridians at risk, will run Sunday, April 12, in the Miami Herald, Sun Sentinel, Orlando Sentinel, Tampa Bay Times, and the Tallahassee Democrat.
Share
This Sunday, April 12, 2026, AHF will run full page ads in five major Florida daily newspapers sharply criticizing Gilead over its drug pricing, which put Florida’s HIV safety net under dangerous strain. The “Greediad” ads (which play on the word “greedy” and the company’s name), will run in the Miami Herald, Sun Sentinel (Fort Lauderdale), Orlando Sentinel, Tampa Bay Times, and the Tallahassee Democrat.
Prices of Gilead’s HIV medications created tremendous financial pressure that contributed to Florida’s decision in January to cut eligibility for ADAP. The program got a brief reprieve when the state legislature voted unanimously last month to allocate $31 million for ADAP as a stopgap to stave off the draconian restrictions and cuts through the end of June.
AHF’s “Greediad” newspaper ads, addressed to “Greedy Gilead,” read in part:
Gilead, your HIV medication Biktarvy carried an annual sticker price of nearly $61,000 in 2025.
That kind of outrageous pricing helped create the financial pressure behind Florida’s decision to cut eligibility for the AIDS Drug Assistance Program, putting 11,500 Floridians at risk of losing HIV coverage.
Most people saw that as a government system in crisis. What they did not see was how years of your price hikes helped push that system closer to the breaking point. Your greed has real consequences. When public HIV care systems are forced to absorb rising drug costs, patients lose stability, providers face greater pressure, and communities across Florida are left more vulnerable.
Gilead, you are making billions while Florida’s HIV safety net pays the price. Instead of helping protect access to lifesaving care, you continue to squeeze the very systems people depend on to stay healthy and alive.
Shame on you Gilead! Stop your attack on the health care safety net!
AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 2.8 million individuals across 50 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. In January 2025, AHF received the MLK, Jr. Social Justice Award, The King Center’s highest recognition for an organization leading work in the social justice arena. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, and follow us on Instagram, Twitter, and TikTok.
Contacts
Media Contacts:
W. Imara Canady, National Director, Communications & Community Engagement, AHF
Cell: 770-940-6555 | imara.canady@ahf.org
Ged Kenslea, AHF Sr. Comms Dir.
(323) 791-5526 | Ged.Kenslea@ahf.org
